These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12713619

  • 1. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.
    Yamamoto H, Oda Y, Saito T, Sakamoto A, Miyajima K, Tamiya S, Tsuneyoshi M.
    Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619
    [Abstract] [Full Text] [Related]

  • 2. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [Abstract] [Full Text] [Related]

  • 3. Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance.
    Molina P, Pellín A, Navarro S, Boix J, Carda C, Llombart-Bosch A.
    Virchows Arch; 1999 Dec; 435(6):596-605. PubMed ID: 10628802
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P, Bartkowiak JK, Szadowska AM, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [Abstract] [Full Text] [Related]

  • 5. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R, Pezzella F, Gatter K, Algara P, Sánchez-Beato M, Martínez P, Martínez JC, Muñoz K, García P, Sánchez L, Kocialkowsky S, Campo E, Orradre JL, Piris MA.
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations.
    Günther T, Schneider-Stock R, Häckel C, Kasper HU, Pross M, Hackelsberger A, Lippert H, Roessner A.
    Mod Pathol; 2000 Jun; 13(6):621-6. PubMed ID: 10874665
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular analysis for p53 and mdm2 in intracranial germ cell tumors.
    Iwato M, Tachibana O, Tohma Y, Nitta H, Hayashi Y, Yamashita J.
    Acta Neuropathol; 2000 Jan; 99(1):21-5. PubMed ID: 10651023
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M, Chiguchi G, Yamada S, Nakajima T, Maung KK, Takagi M, Amagasa T, Tsuchida N.
    J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.